Sequoia Invests $15M In Chinese Healthcare AI Start-up Deep Intelligent Pharma

Login to View

Beijing-based Deep Intelligent Pharma, a healthcare AI start-up providing new drug research and development services for pharmaceutical companies, announced that it has raised a US$15 million series B round of financing from Sequoia Capital China.

Continue reading with a China Money Network subscription

Join Now

Already have an account or paid subscription? Log in